CORCEPT THERAPEUTICS INC Accrued Liabilities, Current
CORCEPT THERAPEUTICS INC (CORT) had Accrued Liabilities, Current of $115.35 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-07-29
- 2026-06-30: Accrued Liabilities, Current $115.35M.
- 2026-03-31: Accrued Liabilities, Current $80.16M.
- 2025-12-31: Accrued Liabilities, Current $90.60M.
- 2025-09-30: Accrued Liabilities, Current $108.45M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $115.35M 10-Q · filed 2026-07-29 | |
| 2026-03-31 | $80.16M 10-Q · filed 2026-04-30 | |
| 2025-12-31 | $90.60M 10-Q · filed 2026-07-29 | |
| 2025-09-30 | $108.45M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $91.07M 10-Q · filed 2025-07-31 | |
| 2025-03-31 | $88.88M 10-Q · filed 2025-05-05 | |
| 2024-12-31 | $90.70M 10-K · filed 2026-02-24 | |
| 2024-09-30 | $79.46M 10-Q · filed 2024-10-30 | |
| 2024-06-30 | $59.25M 10-Q · filed 2024-07-29 | |
| 2024-03-31 | $59.74M 10-Q · filed 2024-05-01 | |
| 2023-12-31 | $51.63M 10-K · filed 2025-02-26 | |
| 2023-09-30 | $69.63M 10-Q · filed 2023-11-01 | |
| 2023-06-30 | $52.18M 10-Q · filed 2023-08-02 | |
| 2023-03-31 | $39.09M 10-Q · filed 2023-05-03 | |
| 2022-12-31 | $30.80M 10-K · filed 2024-02-15 | |
| 2022-09-30 | $29.41M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $24.74M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $32.66M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $27.66M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $24.31M 10-Q · filed 2021-11-03 | |
| 2021-06-30 | $21.51M 10-Q · filed 2021-07-29 | |
| 2021-03-31 | $18.00M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $21.19M 10-K · filed 2022-02-15 | |
| 2020-09-30 | $18.97M 10-Q · filed 2020-11-03 | |
| 2020-06-30 | $22.63M 10-Q · filed 2020-08-04 | |
| 2020-03-31 | $19.59M 10-Q · filed 2020-05-04 | |
| 2019-12-31 | $23.27M 10-K · filed 2021-02-23 | |
| 2019-09-30 | $21.57M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $16.44M 10-Q · filed 2019-08-01 | |
| 2019-03-31 | $18.83M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $23.79M 10-K · filed 2020-02-24 | |
| 2018-09-30 | $20.89M 10-Q · filed 2018-11-02 | |
| 2018-06-30 | $19.11M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $16.41M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $18.74M 10-K · filed 2019-02-26 | |
| 2017-09-30 | $16.25M 10-Q · filed 2017-11-03 | |
| 2017-06-30 | $12.23M 10-Q · filed 2017-08-02 | |
| 2017-03-31 | $9.94M 10-Q · filed 2017-05-02 | |
| 2016-12-31 | $8.95M 10-K · filed 2018-02-28 | |
| 2016-09-30 | $6.87M 10-Q · filed 2016-11-02 | |
| 2016-06-30 | $5.83M 10-Q · filed 2016-08-03 | |
| 2016-03-31 | $4.53M 10-Q · filed 2016-05-04 | |
| 2015-12-31 | $3.26M 10-K · filed 2017-03-06 | |
| 2015-09-30 | $2.83M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $2.51M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $2.42M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $1.88M 10-K · filed 2016-03-10 | |
| 2014-09-30 | $1.54M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $1.62M 10-Q · filed 2014-08-08 | |
| 2014-03-31 | $1.27M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $1.30M 10-K · filed 2015-03-13 | |
| 2013-09-30 | $777.00K 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $812.00K 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $958.00K 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $1.05M 10-K · filed 2014-03-14 | $695.00K 10-K · filed 2013-03-15 |
| 2012-09-30 | $786.00K 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $640.00K 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $781.00K 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $533.00K 10-K · filed 2013-03-15 | $644.00K 10-K · filed 2012-03-13 |
| 2011-09-30 | $755.00K 10-Q · filed 2011-11-08 | |
| 2011-06-30 | $799.00K 10-Q · filed 2011-08-09 | |
| 2010-12-31 | $815.00K 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |